Business ❯Pharmaceutical Industry ❯Mergers and Acquisitions ❯AstraZeneca

Acquisition of Fusion Pharmaceuticals

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline